iShares MSCI India ETF vs Eli Lilly And Co — how do they compare? iShares MSCI India ETF trades at $48.9, while Eli Lilly And Co trades at $1,141 (market cap $1.02T). The key difference: Eli Lilly And Co pays a 0.6% dividend while iShares MSCI India ETF pays none. Which is the better fit depends on your goals.
| INDA | LLY | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $55.29 | $1.24K |
52-Week Low | $45.42 | $625.65 |
Market Cap | — | $1.02T |
Enterprise Value | — | $1.06T |
Dividend Yield | — | 0.6% |
Signals from Pluang's Aura AI — not financial advice
INDA trades at $48.56, down 0.72% on the day, with neutral technical signals overall. The ETF shows bullish moving averages but neutral oscillators, with key support and resistance clustered around $49. Recent news highlights India's strong 7.8% GDP growth (CNBC, 2026-06-05) and ongoing comparisons with other India-focused ETFs amid foreign investor outflows.
The outlook remains mixed: India's robust economic expansion and strategic sector composition offer growth potential, but risks include geopolitical tensions, AI investment underperformance, and regulatory changes in clean energy. Analyst sentiment is cautiously optimistic, with some seeing value in INDA's discount to S&P 500 valuations.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →